Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy

KConFab investigators

Research output: Contribution to journalArticle

13 Scopus citations

Fingerprint Dive into the research topics of 'Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences